Nordea Investment Management Ab Rocket Pharmaceuticals, Inc. Transaction History
Nordea Investment Management Ab
- $92.4 Billion
- Q4 2024
A detailed history of Nordea Investment Management Ab transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 127,270 shares of RCKT stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,270
Previous 126,769
0.4%
Holding current value
$1.3 Million
Previous $2.34 Million
31.7%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RCKT
# of Institutions
210Shares Held
93.3MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$181 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$115 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$63.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$56.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$45.9 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $773M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...